Quick Order Cart

Cat. No. ARG34607

ARSA Knockout HAP1 Polyclonal Cells

  • Product Type:

    Polyclonal Cell Population

  • Species:

    Homo sapiens (Human)

  • Tissue Source:

    Bone Marrow

  • Disease:

    Chronic myeloid leukemia

The ARSA Knockout HAP1 Polyclonal Cells are a CRISPR/Cas9-edited population targeting the ARSA gene in the near-haploid HAP1 line. ARSA cooperates with saposin B to convert sulfatide to galactosylceramide, a step regulated by TFEB and MITF. Its loss triggers lysosomal sulfatide accumulation, impairing myelin stability and recapitulating metachromatic leukodystrophy. This polyclonal knockout model enables myelination studies, drug screening for lysosomal diseases, and gene therapy testing. Researchers can quantify phenotypes via ARSA enzyme assays, LysoTracker flow cytometry, and lipidomics. Contact Ascent Research for further details.

Inquire Now

In stock

Ships next business day


Ask a Question

Shipping Info:

Cryopreserved in vials and shipped on dry ice


Disclaimer:

For Research Use Only

  • Characteristics

    Host Cell

    HAP1

    Sex of Donor

    Male

    Age

    40 years

    Derived From Site

    Bone marrow

    Gene Name

    ARSA

    Gene Identifier

    NCBI Gene ID 410

    Storage

    Liquid nitrogen (LN2)

  • Culture Conditions

    Growth medium

    IMDM

    Supplement(s)

    10% Fetal Bovine Serum, 1% Penicillin-Streptomycin Solution

    Temperature

    37°C

    Atmosphere

    5% COâ‚‚

  • Quality Control

    Sterility testing

    The bacterial, yeast, and fungi are not detected in these cells by daily monitor.

    Mycoplasma testing

    Negative for mycoplasma through PCR analysis

  • Disclaimer

    Intended Use

    This product is intended for laboratory in vitro use only. It is not intended for diagnostic, therapeutic, or clinical applications.

    Disclaimer

    Ascent Research endeavors to provide accurate and up-to-date product information. However, no warranties or representations are made regarding its completeness or reliability. References to scientific literature and patents are for informational purposes only, and the customer assumes sole responsibility for verifying their accuracy.

    By accepting this product, the customer acknowledges and agrees to assume all risks associated with its receipt, handling, storage, disposal, and use, including compliance with all applicable safety and environmental regulations and precautions. Relevant laws, regulations, and ethical guidelines must be followed in conducting any research, modifications, or derivatives derived from this product.

    This product is provided "AS IS", and except as expressly stated herein, Ascent Research disclaims all other warranties, express or implied. Under no circumstances shall Ascent Research, its affiliates, or representatives be liable for indirect, incidental, consequential, or punitive damages arising from the use of this material. While Ascent Research employs rigorous quality control measures, we shall not be held responsible for damages resulting from misidentification or misinterpretation of the provided materials.

Description

The ARSA Knockout HAP1 Polyclonal Cells are a CRISPR/Cas9-edited polyclonal knockout population derived from the HAP1 near-haploid human cell line, with targeted disruption of the ARSA gene. This loss-of-function model enables detailed study of ARSA-mediated lysosomal sulfatide metabolism without requiring single-cell cloning.

HAP1 is a near-haploid, adherent cell line with fibroblast-like morphology, originally isolated from the KBM-7 chronic myeloid leukemia line. Most chromosomes exist in a haploid state, except for disomy 8, making it an ideal host for genetic screening. Single-allele disruption yields a functional knockout, simplifying gene function analysis and enabling clean genotype-phenotype correlation.

ARSA encodes arylsulfatase A, a lysosomal enzyme that catalyzes desulfation of sulfatide to galactosylceramide, a reaction requiring the activator protein saposin B. ARSA transcription is driven by TFEB and MITF, key regulators of lysosomal biogenesis. Loss of ARSA causes sulfatide accumulation, disrupting LAMP1-associated lysosomal integrity and activating cathepsins. This impairs galactosylceramide production, essential for oligodendrocyte maturation and myelin stability, leading to demyelination seen in metachromatic leukodystrophy.

In the HAP1 background, ARSA knockout faithfully recapitulates lysosomal sulfatide storage with complete penetrance due to haploidy. The lack of a second allele eliminates confounding variable expression, enabling robust phenotypic assays. This model is suited for high-content screening, using LysoTracker and anti-sulfatide immunofluorescence to monitor lysosomal dysfunction. The fibroblast-like nature also permits myelination co-culture assays with glial cells to assess functional rescue.

Applications include functional genomics of myelination, metachromatic leukodystrophy disease modeling, and high-throughput drug screening for lysosomal storage disorders. The knockout cells support gene therapy vector evaluation and substrate reduction therapy studies. Assays include ARSA activity measurement by p-nitrocatechol sulfate cleavage, Western blot, RT-qPCR, lipidomics, and flow cytometry for lysosomal mass. Co-culture systems enable myelin readouts. For custom solutions, contact Ascent Research.

Reset Password

    Reach Us Questions? Click Me Here!

    Fill out the form below and a member of our team will contact you shortly!

    *Required field



      Reach Us

      Fill out the form below and a member of our team will contact you shortly!

      *Required field

      Product Inquiry (Optional)